Our research projects

Infections in foot ulcers can be hard to treat and don’t always respond to antibiotics. If this happens, they can result in amputations or sepsis.

Dr Freya Harrison wants to find new types of antibiotics that could be used to effectively treat infections in foot ulcers. In the future, this could improve the quality of people with diabetes’ lives and reduce the number of amputations.

The DiRECT trial is finding out whether a weight management programme, including a low-calorie diet, can put Type 2 diabetes into remission for the long-term. This project will look at the cost effectiveness of this programme when delivered through GP care.

This will give the NHS important information to help work out if this kind of treatment could be offered to people with Type 2 diabetes in the future. 

Insulin resistance is a key feature of Type 2 diabetes. It affects the ability of the body’s cells to take in glucose and causes high blood glucose levels.

Professor Bryant will explore whether proteins involved in this process don’t work properly in people with Type 2 diabetes. This research could improve our understanding of what causes Type 2 diabetes and how to treat it.

Dr Martin Rutter plans to work out if sleep problems can help to predict who’s at risk of Type 2 diabetes. He’ll also look at whether sleep patterns in people with Type 2 diabetes can affect their blood glucose control and risk of complications. This research could help to prevent some people developing Type 2 diabetes and improve the health of people living with the condition.

Flash Glucose Monitoring gives people with diabetes a simple and painless way to monitor their blood glucose levels. But not everyone who would benefit has access to this life-changing technology. Dr Lalantha Leelarathna will compare the impact and costs of Flash to finger pricks tests in people with Type 1 diabetes. This will provide important evidence that could help make Flash more widely available on the NHS, to transform the lives of people with Type 1 diabetes.

Retinopathy is an eye complication of diabetes and can lead to blindness. Current treatments for retinopathy only address the end-stages of the disease, when the eye is already significantly damaged. Professor Curtis and his research team want to test a new drug that could slow or stop retinopathy earlier on in its development.